Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had revenue of $196.83M in the quarter ending September 30, 2024, with 78.29% growth. This brings the company's revenue in the last twelve months to $715.22M, up 162.10% year-over-year. In the year 2023, Apellis Pharmaceuticals had annual revenue of $396.59M with 425.83% growth.

• Revenue (ttm): $715.22M
• Revenue Growth: +162.10%
• P/S Ratio: 4.73
• Revenue / Employee: $1,013,054
• Employees: 706
• Market Cap: 3.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.